Next Article in Journal
Neuronal Depolarization Induced RNA m5C Methylation Changes in Mouse Cortical Neurons
Previous Article in Journal
CNP, the Third Natriuretic Peptide: Its Biology and Significance to the Cardiovascular System
Previous Article in Special Issue
Functional Remodeling of the Contractile Smooth Muscle Cell Cortex, a Provocative Concept, Supported by Direct Visualization of Cortical Remodeling
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biology
Volume 11
Issue 7
10.3390/biology11070989
biology-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Does the Actin Network Architecture Leverage Myosin-I Functions?

by
Julien Pernier
1 and
Kristine Schauer
2,*
1
Institute for Integrative Biology of the Cell (I2BC), Centre National de la Recherche Scientifique (CNRS), Commissariat à L’Énergie Atomique et aux Énergies Alternatives (CEA), Université Paris-Saclay, 91198 Gif-sur-Yvette, France
2
Tumor Cell Dynamics Unit, Inserm U1279, Gustave Roussy Institute, Université Paris-Saclay, 94800 Villejuif, France
*
Author to whom correspondence should be addressed.
Biology 2022, 11(7), 989; https://doi.org/10.3390/biology11070989
Submission received: 19 April 2022 / Revised: 24 June 2022 / Accepted: 26 June 2022 / Published: 29 June 2022
(This article belongs to the Special Issue Reviews in Actin Cytoskeletal Dynamics)
Browse Figures
Review Reports Versions Notes

Abstract

:

Simple Summary

Here, we review the known characteristics and functions of proteins called myosin-I. These mechanoenzymes belong to an ancient family of actin-dependent motors, found throughout eukaryotic cells, which are characterized by intracellular membrane-bound compartments. We elaborate on the surprising fact that many different functions have been attributed to these proteins, and highlight that we now need to understand how their enzymatic activity supports these functions. We propose to focus on the remodeling of the actin cytoskeleton, a higher-order dynamic scaffold typical for eukaryotic cells.

Abstract

The actin cytoskeleton plays crucial roles in cell morphogenesis and functions. The main partners of cortical actin are molecular motors of the myosin superfamily. Although our understanding of myosin functions is heavily based on myosin-II and its ability to dimerize, the largest and most ancient class is represented by myosin-I. Class 1 myosins are monomeric, actin-based motors that regulate a wide spectrum of functions, and whose dysregulation mediates multiple human diseases. We highlight the current challenges in identifying the “pantograph” for myosin-I motors: we need to reveal how conformational changes of myosin-I motors lead to diverse cellular as well as multicellular phenotypes. We review several mechanisms for scaling, and focus on the (re-) emerging function of class 1 myosins to remodel the actin network architecture, a higher-order dynamic scaffold that has potential to leverage molecular myosin-I functions. Undoubtfully, understanding the molecular functions of myosin-I motors will reveal unexpected stories about its big partner, the dynamic actin cytoskeleton.

1. Introduction

The actin cytoskeleton plays a crucial role in cell morphogenesis and function. The main partners of cortical actin are the molecular motors of the myosin superfamily. Myosins are mechanoenzymes that use the hydrolysis of ATP as an energy source to interact with actin filaments, and to generate force on them. Myosins are present in almost all eukaryotes, missing only in the metamonads Trichomonas vaginalis and Giardia lamblia, and some red algae, Cyanidioschyzon merolae and Chondrus crispus [1]. Phylogenetic analyses of the myosin gene family indicate that 2–6 myosin genes, encoding different protein domain architectures, were present in the last eukaryotic common ancestor (LECA), revealing an ancestral role of myosins in eukaryotic evolution [1]. It has been proposed that there are at least 79 distinct myosin classes in extant eukaryotes, 13 of which are found in humans [2]. Indeed, humans also have one of the highest numbers of myosin genes (total of 38) and one of the richest protein domain diversities attached to the myosin motor domain [1]. Yet, the function of most of these myosins is not known and an understanding of myosin diversity is lacking.
Myosin research started with muscle myosin, a class 2 myosin. The mechano-chemical characteristics of the muscle myosin heavy chain has strongly influenced our thinking about these actin-dependent motor proteins. For instance, historic classification groups myosins into two categories, named conventional myosin-II, with their long tails necessary for dimerization, and unconventional myosins, with distinct tails associated with different roles. Class 2 myosins (Myh genes in humans) dimerize and slide antiparallel actin filaments against each other. In muscle, these activities lead to muscle contraction, whereas in other cells, non-muscle myosin-II a/b (Myh9 and Myh10 in humans) crosslinks actin to (i) produce the actin retrograde flow [3], (ii) regulate cell cortex tension [4,5,6], or (iii) pull on adhesive structures [7]. In addition to myosin-II, some other myosins, such as myosin-V (Myo5) and -XVIII (Myo18), act as dimers that interact through their C-terminal coiled-coils. However, the majority of myosins are considerably divergent, including myosins I, III, VI, VII, IX, X, XV, and XIX (Myo genes in human), and act as monomers [8].
To date, only amorphean, apicomplexan and plant myosins have been studied in detail, and functional data are missing for most of the myosin classes. Although our understanding of myosin functions is heavily based on myosin-II and its ability to dimerize, the largest and most ancient class is represented by monomeric myosin-I. In this review, we will focus on these important myosins. We will highlight current challenges to understand how a single-headed, actin-based motor could regulate diverse functions, and how its dysregulation mediates multiple human diseases. We review several mechanisms that could leverage the molecular conformational changes of myosin-I through scales, and thus function as a cellular or organism-level “pantograph” for myosin-I motors.

1.1. Molecular Domains of Myosin-I

Class 1 myosins are non-processive monomeric motors that are composed of three main domains: head, neck and tail [9]. It has been proposed to classify myosin-I members into five subclasses based on a phylogenetic analysis of their motor and additional domain structure [1]. Four of these subclasses are present in humans, and these orthologs have been used to name the subclasses of myosin-I, namely subclasses c/h, d/g, and a/b as well as less related f isoforms representing long tails (Figure 1). Additionally, a myosin-Ik subclass was found that was lost in metazoans and is only present in choanoflagellates, filastereans, ichthyosporeans, and Thecamonas trahens [1].
The N-terminus of all class 1 myosins is called the head domain and contains the catalytic motor domain. It binds filamentous actin (F-actin) in an ATP-regulated manner (Figure 2). ATP-dependent motor activity leads to a movement of myosin-I towards the plus end of actin filaments (barbed ends). This conserved catalytic domain is followed by a neck region that mostly has one or more consensus sequences called the IQ motif. They can bind regulatory proteins, such as calmodulin or calmodulin-like light chains. Finally, the C-terminal tail contains a myosin-I family tail homology 1 (TH1) domain, which includes a pleckstrin homology (PH) domain known to bind a variety of anionic phospholipids. Subclasses c/h, d/g, a/b and k consist of a myosin head domain followed by a neck, composed of IQ repeats (PF00612), and a C-terminal myosin TH1 domain (PF06017). Long-tailed isoforms of myosin-If (Myo1E and Myo1F) have a myosin head domain followed by one IQ motif, a myosin TH1 domain and a C-terminal proline rich domain, which includes a src-homology (SH3) domain, involved in the binding of other proteins. The characteristic protein domain organization results in the localization of myosin-I to cellular membranes, the plasma membrane and intracellular organelles. Phosphoinositides, which are dynamic membrane phospholipids and master regulators in intracellular trafficking and signaling, control the specific binding of myosin-I to cellular membranes through the PH domain [10]. Moreover, the preference of motor domains for different actin filament populations could influence cellular localization [11]. Finally, the presence of additional domains (such as the SH3 domain) determines specific interactions with other protein-binding partners. Collectively, class 1 myosins connect the actin cytoskeleton to cellular membranes rather than crosslinking actin, which is the main function of class 2 myosin isoforms.

1.2. Myosin-I Members Have Diverse Functions

Myosin-I motors represent the largest and the most ancient myosin class in eukaryotes. The number of myosin-I genes strongly varies in different organisms, e.g., the yeast Saccharomyces cerevisiae has two long-tailed myosins, Myo3p and Myo5p [13], whereas Schizosaccharomyces pombe has only Myo1p [14]. Dictyostelium has seven myosin-I isoforms (Myo1A, B, C, D, E, F and K), three short-tailed (1A, 1E and 1F), three long-tailed (1B, 1C and 1D) and another myosin-I (Myo1K) with no tail [15]. Eight members (Myo1A, B, C, D, E, F and H) are known in humans. Given the ancient nature of myosin-I, it is not surprising that very diverse functions have been associated with this motor protein in different organisms and tissues [9]. The non-exhaustive functions of the different human subtypes are listed below and are summarized in Table 1.
Moreover, mutations in myosin-I motors have been found in several diseases [9], including kidney disease [44,45,46,47,48], deafness [49,50,51,52,53], arteriosclerosis [54] and have been linked to the mandibular prognathism phenotype [55] (summarized in Table 2).
Finally, several knock out murine models of myosin-I paralogs have been established and their phenotypes are summarized in Table 3.
The myosin a/b subclass, Myo1A, is expressed in intestine [16] where it acts as a linker between actin bundles and the microvillus membrane. Myo1B has three different isoforms (Myo1Ba, b and c) containing four to six IQ motifs. It is expressed in many tissues such as lung, liver, heart, and brain [63]. Myo1B interacts with the transmembrane tyrosine kinase receptors EPHB2 and controls cell repulsion and morphology [17,18]. Myo1B also regulates the formation of filopodia in growth cones and controls the extension of branched actin networks that impact axon elongation [19]. Moreover, Myo1B has been shown to have intracellular functions, promoting the formation of tubules at the Trans-Golgi-Network (TGN) [20]. It has been proposed that its mechano-enzymatic activity bends membranes and facilitates tube extraction [21].
The myosin c/h subclass is exemplary of myosin-I regulation of a broad range of biological processes and is the ubiquitously expressed Myo1C isoform. Myo1C has been implicated in a variety of different functions, including mechanical transduction in the ear [24], the regulation of cellular membrane tension [25], cholesterol transport [26], tethering of vesicles [27,28], autophagosome–lysosome fusion [29], the regulation of metabolism [27,32,33,34,35,36], and the establishment of chirality in Drosophila [30]. Interestingly, mutations in Myo1C manifest in different diseases (Table 2), from glucose-uptake defects [56] to hearing loss [24]. The best-studied function of Myo1C is its role in the docking of GLUT4-containing vesicles to the plasma membrane in response to insulin stimulation [27,32,33,34,35,36]. More generally, Myo1C has been shown to control exocytosis in secretory cells and has been implicated in the VEGF-induced delivery of VEGFR2 to the cell plasma membrane [37] and in surfactant exocytosis (lipo-protein secretion) [38]. Concomitantly, although Myo1C shows a strong accumulation at the plasma membrane in cholesterol-rich lipid microdomains [26], it can also be found in minor pools such as on recycling endosomes [26] or at the proximity of the Golgi complex [28]. Myo1C’s paralog, Myo1H, although little studied, has recently been implicated in Mandibular Prognathism [14].
The myosin d/g subclass, Myo1D, is widely expressed, with the highest expression being seen in the brain. Myo1D has two IQ motifs that bind calmodulin [64]. Ca2+ binding to calmodulin can inhibit ATPase activity [65]. In rats, Myo1D functions at adherens junctions. It also influences the establishment and/or maintenance of rotational planar cell polarity in the ciliated tracheal and ependymal epithelial cells [40]. Myo1G is specifically expressed in hematopoietic cells [66]. In B lymphocytes, it is involved in the processes of phagocytosis and exocytosis [43].
The long-tailed myosin e/f subclass are both long-tailed isoforms expressed in hematopoietic cells. The widely expressed long-tailed Myo1E and its homologs in S. cerevisiae (Myo3p and Myo5p) interact through their SH3 domain with the Wiskott–Aldrich syndrome proteins (WASP). This interaction promotes Arp2/3-mediated actin polymerization during clathrin-mediated endocytosis [41,42]. Moreover, Myo1E localizes to actin polymerization sites in lamellipodia [67]. Myo1F is a long-tailed myosin that, in addition to a TH1, also contains a C-terminal proline-rich domain and a src-homology (SH3) domain, involved in the binding of other proteins. It is selectively expressed in neutrophils and regulates adhesion to the extracellular environment [61].
Collectively, and as reviewed in more detail previously [9], a wide range of biological processes and complex cellular phenomena have been shown to depend on individual myosin-I isoforms in different cellular and developmental systems. In addition to an enzymatic motor domain, most myosin-I isoforms contain a very short tail, only consisting of a pleckstrin homology (PH) domain for phosphatidylinositol binding [68]. Therefore, it is unclear how these relatively simple molecules and their mechano-enzymatic activity control a wide spectrum of cellular functions.

2. Challenges to Leverage the Molecular Conformational Changes of Myosin-I through Scales

It is intriguing how many different cellular roles, related to membrane dynamics and trafficking, are played by individual myosin-I motors [9]. The challenge holds up to connect the mechano-enzymatic activity of these molecules to cellular and organism-level functions [9], including impressive phenotypes of chirality regulation in Drosophila. In other words, it is high time we understood the scaling from molecular conformational changes of a rather simple molecule to cell and organism functions, and to identify the “pantograph” for myosin-I motors. We particularly argue that we need to leave behind our thinking of myosin functions based on dimerization (as found for myosin-II) or attributed to the tail domain only, and consider how the conformational changes of the motor domain of myosin-I could support different functions in a monomeric form. We review several mechanisms that have been proposed for scaling, from the deformation of membranes to the regulation of membranes and cortical tension, and finally focus on the emerging role of class 1 myosins in the remodeling of a higher-order dynamic scaffold, represented by the actin cytoskeleton.

2.1. Membrane Remodeling

Given that myosin-I isoforms link membranes to the actin cytoskeleton, it has been proposed that they also deform membranes and participate in tubulation at the plasma membrane or the surface of organelles [9]. This function is often associated with plasma membrane invagination during different types of endocytosis [69,70], changes in plasma membrane deformability (or plasma membrane tension) during protrusion formation [71,72,73,74] or intracellular membrane trafficking [20,75,76,77]. Membrane deformation functions of myosin-I have also been shown to occur working with processive microtubule-based motors of the kinesin family [20,78]. Strong experimental support for myosin-I function in membrane deformation comes from in vitro studies. It has been shown that the myosin-I member Myo1B can tubulate giant unilamellar vesicles along fascin-bundled actin in an in vitro reconstitution assay [21]. However, it is surprising that the PH-domain-dependent membrane attachment and dynamic actin binding provides stable anchorages for membrane deformations. Although the regulation of membrane tubulation, and therefore the control of intracellular trafficking could impact many functions indirectly, some of the phenotypes associated with myosin-I depletion/mutations are difficult to explain. For instance, chirality phenotypes rely on asymmetric cellular activity. Thus, membrane remodeling only provides limited explanations of how molecular myosin-I functions could scale over several dimensions.

2.2. Membrane and Cortical Tension

The actin-membrane linker function of myosin-I could also regulate cortical tension, a mechanical property of the plasma membrane with the underlying actin cortex [79]. Yet, cortical tension results from applied contractile stresses that pull on actin filaments through motor crosslinking, for instance. It has been proposed that cortical tension is most prominently controlled by myosin-II activity [4,5,6]. Because monomeric myosin-I motors do not crosslink actin, it is less obvious how they could develop contractile stresses. The molecular role of myosin-I at the cell cortex is not well understood. Interestingly, cortex tension strongly cross-talks with cell–substrate and cell–cell adhesion in a multicellular context. Indeed, myosin-I motors have been localized at cell–cell adhesions and adherens junctions and have also been implicated in ephrin receptor B2 (EphB2)-dependent cell–cell repulsion [17]. The balance between cell–cell adhesion and cell–cell repulsion is important for tissue patterning and homeostasis, and thus could regulate chirality establishment or the maintenance of rotational planar cell polarity [40]. Yet, the maintenance of membrane and/or cortical tension, as well as cell–cell adhesion functions, rely on the underlying actin cytoskeleton and therefore the role of myosin-I in the control of actin architecture needs to be further considered.

2.3. Role in Actin Remodeling

A mechanism that could allow one to scale the mechano-enzymatic activity of myosin-I over several dimensions, from cellular compartments to whole cells and organisms, is the dynamic remodeling of a bigger scaffold, the actin cytoskeleton. Indeed, several lines of evidence exist that myosin-I changes actin architecture in vitro, in cellulo and in vivo [22,23,43,58,80]. For instance, several myosin-I motors have been proposed to regulate cortical actin architecture in the neuronal growth cone [80] and in B cells at the immunological synapse [81]. Experiments on adhesive micropatterns, which provide good control and reproducibility to monitor the actin cytoskeleton [82,83], confirm that the depletion of Myo1C leads to the loss of cellular F-actin [28]. Strong evidence for a direct role in actin reorganization of class 1 myosins comes from biochemical studies of human Myo1B which has been found to act as an actin de-polymerase [22].
Particularly, it is emerging that myosin-I motors regulate the balance between actin bundles and Arp2/3-dependent branched actin. In vitro and in vivo data suggest that myosin-I motors avoid tropomyosin-coated actin filaments [84,85,86,87] and instead prefer Arp2/3-nucleated actin [88]. Moreover, the depletion of Myo1C mimics the loss of the Arp2/3 complex, whereas the manipulation of Myo1B affects the distribution of Arp2/3 and associated branched F-actin [20], and flattens branched actin filaments in vitro [23]. Indeed, it has been highlighted that many class 1 myosins appear to be able to recruit, directly or indirectly, the Arp2/3 complex [89]. In Dictyostelium, Myo1E and Myo1F are involved in actin dynamics at the leading edge, by interacting with Arp2/3 through CARMIL (capping protein, Arp2/3, myosin-I linker protein) [90]. The long-tailed class 1 myosins, Myo1E in human, and Myo3p and Myo5p in yeast, also interact with the actin-polymerization factors neural Wiskott–Aldrich syndrome protein (N-WASP) and with the Arp2/3 complex, through a sequence at the end of their long tail domain [41,91]. Yet, although yeast class 1 myosins facilitate Arp2/3 nucleation through their tail domain, it has been recently suggested that actin network growth relied on their motor domain [92]. Because a deficiency of myosin motors could not be rescued by increasing actin nucleation, it was proposed that class 1 myosins stimulate actin filament elongation. It was suggested that the myosin-I motor domain facilitates the addition of new actin monomers to existing filaments, rather than supporting nucleation [92]. Thus, in addition to indirectly affecting actin dynamics by recruiting factors that are involved in actin nucleation, polymerization or stabilization, myosin-I could regulate actin dynamics directly through its motor domain. Interestingly, Drosophila Myo1C and Myo1D control cellular and larvae chirality [30,31], which were thought to rely on the gliding of actin filaments in circular paths revealed in in vitro assays. Alternatively, the higher-scale propagation of the chiral Arp2/3 molecule by the actin network could be envisioned. Thus, we propose to revisit our understanding of class 1 myosins as motors involved in actin rearrangements [22,23,28,92].

3. Conclusions

Actin network organization is at the center of mammalian cell morphogenesis and function. Thus, to fully understand this relationship, we must understand the role and transitions between different types of actin networks. Because myosin motor proteins are prime partners of F-actin, it is important to obtain a true, molecular comprehension of the function of the ancient and ubiquitously expressed class I myosins. A wide range of biological processes have been shown to depend on them in different cellular and developmental systems. However, the molecular mechanisms of different functions achieved by this single-headed, non-dimerizing motor is not clear. After revealing different processes relying on myosin-I, it is now important to integrate the cell biological, biochemical, biophysical and structural features of myosin-I motors.
An emerging, or re-emerging, function of class 1 myosins is the regulation of the actin architecture, which has the potential to leverage molecular myosin-I functions to diverse cellular as well as multicellular phenotypes. In this context, we particularly need to re-evaluate the function of the catalytic motor domain in actin reorganization. Could the motor domain regulate actin dynamics and rearrangements? Could the interaction of the myosin-I motor domain with actin impact the global actin architecture? For this, it is essential to piece together different approaches in continued interdisciplinary research across scales, from molecules and networks to cells and organisms. A strong impact could have in vitro bottom-up approaches, which not only test biochemical activity, but also build up in size and include geometrical constrains mimicking cell constituents, as well as cell dimensions. For instance, assays on fluid-supported lipid bilayers, which mimic cell membranes [22], are important to better estimate the impact of force generation by myosin-I motors. Such in vitro reconstitution approaches need to be further integrated with scalable micropatterned environments, which increase dimensions and allow the study of emerging properties, such as the network architecture of the actin cytoskeleton. Together, such in vitro systems will allow further testing into how the actin network organization could be controlled by non-conventional myosins. Further, their comparison with cells could reveal novel mechanistic explanations for the pleiotropic roles played by these motors in cells and at the scale of organisms. This will provide a foundation to understand functions such as mechanoelectrical transduction in the ear [24], the regulation of cellular membrane tension [25], cholesterol transport [26], tethering secretory vesicles for glucose uptake [27,28], autophagosome–lysosome fusion [29], chirality establishment in Drosophila [30] and potentially unexpected novel ‘moon light functions’ of Myo1C in the nucleus [39]. Understanding the molecular function of myosin-I motors will also facilitate the development of targeted therapeutics. Only a few inhibitors that target the conserved motor domain of class 1 myosins have been described, for instance, the natural compound pentachloropseudilin (PCIP), a reversible and allosteric inhibitor of myosin ATPase activity. Myosin-I inhibitors are employed as highly species-specific fungicide [93]. Selective myosin-I inhibitors and activators could have therapeutic potential for the treatment of myosin dysfunctions or overactivity, or could be used to specifically target pathogenic eukaryotes. Finally, relating myosin-I activity to the organization of the actin network will shed light on the exciting story about the extensive remodeling of this cytoskeleton system across eukaryotes.

Author Contributions

Writing—review and editing, K.S. and J.P.; funding acquisition, K.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research and the APC was funded by ANR grant MYOCORTEX n°ANR-21-CE13-0010.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Acknowledgments

We would like to acknowledge Olena Pylypenko, Institut Curie, France, for providing Figure 2. We thank all members of the Schauer and Le Clainche team for critical discussions.

Conflicts of Interest

The sponsors had no role in the design, execution, interpretation, or writing of the study.

References

  1. Sebé-Pedrós, A.; Grau-Bové, X.; Richards, T.A.; Ruiz-Trillo, I. Evolution and classification of myosins, a paneukaryotic whole-genome approach. Genome Biol. Evol. 2014, 6, 290–305. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Kollmar, M.; Mühlhausen, S. Myosin repertoire expansion coincides with eukaryotic diversification in the Mesoproterozoic era. BMC Evol. Biol. 2017, 17, 211. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Burnette, D.T.; Manley, S.; Sengupta, P.; Sougrat, R.; Davidson, M.W.; Kachar, B.; Lippincott-Schwartz, J. A role for actin arcs in the leading-edge advance of migrating cells. Nat. Cell Biol. 2011, 13, 371–382. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Maître, J.-L.; Niwayama, R.; Turlier, H.; Nédélec, F.; Hiiragi, T. Pulsatile cell-autonomous contractility drives compaction in the mouse embryo. Nat. Cell Biol. 2015, 17, 849–855. [Google Scholar] [CrossRef]
  5. Maître, J.-L.; Turlier, H.; Illukkumbura, R.; Eismann, B.; Niwayama, R.; Nédélec, F.; Hiiragi, T. Asymmetric division of contractile domains couples cell positioning and fate specification. Nature 2016, 536, 344–348. [Google Scholar] [CrossRef] [Green Version]
  6. Schliffka, M.F.; Tortorelli, A.F.; Özgüç, Ö.; de Plater, L.; Polzer, O.; Pelzer, D.; Maître, J.-L. Multiscale analysis of single and double maternal-zygotic Myh9 and Myh10 mutants during mouse preimplantation development. eLife 2021, 10, e68536. [Google Scholar] [CrossRef]
  7. Vigouroux, C.; Henriot, V.; Le Clainche, C. Talin dissociates from RIAM and associates to vinculin sequentially in response to the actomyosin force. Nat. Commun. 2020, 11, 3116. [Google Scholar] [CrossRef]
  8. Peckham, M. Coiled coils and SAH domains in cytoskeletal molecular motors. Biochem. Soc. Trans. 2011, 39, 1142–1148. [Google Scholar] [CrossRef]
  9. McIntosh, B.; Ostap, E.M. Myosin-I molecular motors at a glance. J. Cell Sci. 2016, 129, 2689–2695. [Google Scholar] [CrossRef] [Green Version]
  10. McConnell, R.E.; Tyska, M.J. Leveraging the membrane—Cytoskeleton interface with myosin-1. Trends Cell Biol. 2010, 20, 418–426. [Google Scholar] [CrossRef] [Green Version]
  11. Ruppert, C.; Godel, J.; Muller, R.; Kroschewski, R.; Reinhard, J.; Bahler, M. Localization of the rat myosin I molecules myr 1 and myr 2 and in vivo targeting of their tail domains. J. Cell Sci. 1995, 108, 3775–3786. [Google Scholar] [CrossRef]
  12. Mentes, A.; Huehn, A.; Liu, X.; Zwolak, A.; Dominguez, R.; Shuman, H.; Ostap, E.M.; Sindelar, C.V. High-resolution cryo-EM structures of actin-bound myosin states reveal the mechanism of myosin force sensing. Proc. Natl. Acad. Sci. USA 2018, 115, 1292–1297. [Google Scholar] [CrossRef] [Green Version]
  13. Brown, S. Myosins in yeast. Curr. Opin. Cell Biol. 1997, 9, 44–48. [Google Scholar] [CrossRef]
  14. Berg, J.S.; Powell, B.C.; Cheney, R.E. A millennial myosin census. Mol. Biol. Cell 2001, 12, 780–794. [Google Scholar] [CrossRef] [Green Version]
  15. Kim, S.V.; Flavell, R.A. Myosin I: From yeast to human. Cell. Mol. Life Sci. 2008, 65, 2128–2137. [Google Scholar] [CrossRef]
  16. Benesh, A.E.; Nambiar, R.; McConnell, R.E.; Mao, S.; Tabb, D.L.; Tyska, M.J. Differential localization and dynamics of class I myosins in the enterocyte microvillus. Mol. Biol. Cell 2010, 21, 970–978. [Google Scholar] [CrossRef] [Green Version]
  17. Prospéri, M.-T.; Lépine, P.; Dingli, F.; Paul-Gilloteaux, P.; Martin, R.; Loew, D.; Knölker, H.-J.; Coudrier, E. Myosin 1b functions as an effector of EphB signaling to control cell repulsion. J. Cell Biol. 2015, 210, 347–361. [Google Scholar] [CrossRef] [Green Version]
  18. Prospéri, M.-T.; Pernier, J.; Lachuer, H.; Coudrier, E. Plekhh1, a partner of myosin 1 and an effector of EphB2 controls the cortical actin network for cell repulsion. J. Cell Sci. 2021, 134, jcs258802. [Google Scholar] [CrossRef]
  19. Iuliano, O.; Yoshimura, A.; Prospéri, M.-T.; Martin, R.; Knölker, H.-J.; Coudrier, E. Myosin 1b promotes axon formation by regulating actin wave propagation and growth cone dynamics. J. Cell Biol. 2018, 217, 2033–2046. [Google Scholar] [CrossRef]
  20. Almeida, C.G.; Yamada, A.; Tenza, D.; Louvard, D.; Raposo, G.; Coudrier, E. Myosin 1b promotes the formation of post-Golgi carriers by regulating actin assembly and membrane remodelling at the trans-Golgi network. Nat. Cell Biol. 2011, 13, 779–789. [Google Scholar] [CrossRef]
  21. Yamada, A.; Mamane, A.; Lee-Tin-Wah, J.; Di Cicco, A.; Prévost, C.; Levy, D.; Joanny, J.-F.; Coudrier, E.; Bassereau, P. Catch-bond behaviour facilitates membrane tubulation by non-processive myosin 1b. Nat. Commun. 2014, 5, 3624. [Google Scholar] [CrossRef]
  22. Pernier, J.; Kusters, R.; Bousquet, H.; Lagny, T.; Morchain, A.; Joanny, J.-F.; Bassereau, P.; Coudrier, E. Myosin 1b is an actin depolymerase. Nat. Commun. 2019, 10, 5200. [Google Scholar] [CrossRef]
  23. Pernier, J.; Morchain, A.; Caorsi, V.; Bertin, A.; Bousquet, H.; Bassereau, P.; Coudrier, E. Myosin 1b flattens and prunes branched actin filaments. J. Cell Sci. 2020, 133, jcs247403. [Google Scholar] [CrossRef] [PubMed]
  24. Lin, T.; Greenberg, M.J.; Moore, J.R.; Ostap, E.M. A hearing loss-associated myo1c mutation (R156W) decreases the myosin duty ratio and force sensitivity. Biochemistry 2011, 50, 1831–1838. [Google Scholar] [CrossRef] [Green Version]
  25. Dai, J.; Ting-Beall, H.P.; Hochmuth, R.M.; Sheetz, M.P.; Titus, M.A. Myosin I contributes to the generation of resting cortical tension. Biophys. J. 1999, 77, 1168–1176. [Google Scholar] [CrossRef] [Green Version]
  26. Brandstaetter, H.; Kendrick-Jones, J.; Buss, F. Molecular roles of Myo1c function in lipid raft exocytosis. Commun. Integr. Biol. 2012, 5, 508–510. [Google Scholar] [CrossRef]
  27. Boguslavsky, S.; Chiu, T.; Foley, K.P.; Osorio-Fuentealba, C.; Antonescu, C.N.; Bayer, K.U.; Bilan, P.J.; Klip, A. Myo1c binding to submembrane actin mediates insulin-induced tethering of GLUT4 vesicles. Mol. Biol. Cell 2012, 23, 4065–4078. [Google Scholar] [CrossRef]
  28. Capmany, A.; Yoshimura, A.; Kerdous, R.; Caorsi, V.; Lescure, A.; Del Nery, E.; Coudrier, E.; Goud, B.; Schauer, K. MYO1C stabilizes actin and facilitates arrival of transport carriers at the Golgi apparatus. J. Cell Sci. 2019, 132, jcs225029. [Google Scholar] [CrossRef] [Green Version]
  29. Brandstaetter, H.; Kishi-Itakura, C.; A Tumbarello, D.; Manstein, D.J.; Buss, F. Loss of functional MYO1C/myosin 1c, a motor protein involved in lipid raft trafficking, disrupts autophagosome-lysosome fusion. Autophagy 2014, 10, 2310–2323. [Google Scholar] [CrossRef] [Green Version]
  30. Lebreton, G.; Géminard, C.; Lapraz, F.; Pyrpassopoulos, S.; Cerezo, D.; Spéder, P.; Ostap, E.M.; Noselli, S. Molecular to organismal chirality is induced by the conserved myosin 1D. Science 2018, 362, 949–952. [Google Scholar] [CrossRef]
  31. Pyrpassopoulos, S.; Feeser, E.A.; Mazerik, J.N.; Tyska, M.J.; Ostap, E.M. Membrane-bound Myo1c powers asymmetric motility of actin filaments. Curr. Biol. 2012, 22, 1688–1692. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Bose, A.; Guilherme, A.; Robida, S.I.; Nicoloro, S.M.C.; Zhou, Q.L.; Jiang, Z.Y.; Pomerleau, D.P.; Czech, M.P. Glucose transporter recycling in response to insulin is facilitated by myosin Myo1c. Nature 2002, 420, 821–824. [Google Scholar] [CrossRef] [PubMed]
  33. Bose, A.; Robida, S.; Furcinitti, P.S.; Chawla, A.; Fogarty, K.; Corvera, S.; Czech, M.P. Unconventional myosin Myo1c promotes membrane fusion in a regulated exocytic pathway. Mol. Cell. Biol. 2004, 24, 5447–5458. [Google Scholar] [CrossRef] [Green Version]
  34. Yip, M.F.; Ramm, G.; Larance, M.; Hoehn, K.L.; Wagner, M.C.; Guilhaus, M.; James, D.E. CaMKII-Mediated phosphorylation of the myosin motor Myo1c Is required for insulin-stimulated GLUT4 translocation in adipocytes. Cell Metab. 2008, 8, 384–398. [Google Scholar] [CrossRef] [Green Version]
  35. Chen, X.-W.; Leto, D.; Chiang, S.-H.; Wang, Q.; Saltiel, A.R. Activation of RalA is required for insulin-stimulated Glut4 trafficking to the plasma membrane via the exocyst and the motor protein Myo1c. Dev. Cell 2007, 13, 391–404. [Google Scholar] [CrossRef]
  36. Huang, S.; Czech, M.P. The GLUT4 glucose transporter. Cell Metab. 2007, 5, 237–252. [Google Scholar] [CrossRef] [Green Version]
  37. Tiwari, A.; Jung, J.-J.; Inamdar, S.M.; Nihalani, D.; Choudhury, A. The myosin motor Myo1c is required for VEGFR2 delivery to the cell surface and for angiogenic signaling. Am. J. Physiol. Circ. Physiol. 2013, 304, H687–H696. [Google Scholar] [CrossRef] [Green Version]
  38. Kittelberger, N.; Breunig, M.; Martin, R.; Knölker, H.-J.; Miklavc, P. The role of myosin 1c and myosin 1b for surfactant exocytosis. J. Cell Sci. 2016, 129, 1685–1696. [Google Scholar] [CrossRef] [Green Version]
  39. Sarshad, A.; Sadeghifar, F.; Louvet, E.; Mori, R.; Böhm, S.; Al-Muzzaini, B.; Vintermist, A.; Fomproix, N.; Östlund, A.-K.; Percipalle, P. Nuclear myosin 1c facilitates the chromatin modifications required to activate rRNA gene transcription and cell cycle progression. PLoS Genet. 2013, 9, e1003397. [Google Scholar] [CrossRef]
  40. Hegan, P.S.; Ostertag, E.; Geurts, A.M.; Mooseker, M.S. Myosin Id is required for planar cell polarity in ciliated tracheal and ependymal epithelial cells: Myo1d is a determinant of planar cell polarity. Cytoskeleton 2015, 72, 503–516. [Google Scholar] [CrossRef] [Green Version]
  41. Lechler, T.; Shevchenko, A.; Shevchenko, A.; Li, R. Direct involvement of yeast type I myosins in Cdc42-dependent actin polymerization. J. Cell Biol. 2000, 148, 363–374. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Cheng, J.; Grassart, A.; Drubin, D.G. Myosin 1E coordinates actin assembly and cargo trafficking during clathrin-mediated endocytosis. Mol. Biol. Cell 2012, 23, 2891–2904. [Google Scholar] [CrossRef]
  43. Maravillas-Montero, J.L.; López-Ortega, O.; Patiño-López, G.; Santos-Argumedo, L. Myosin 1g regulates cytoskeleton plasticity, cell migration, exocytosis, and endocytosis in B lymphocytes: Molecular immunology. Eur. J. Immunol. 2013, 44, 877–886. [Google Scholar] [CrossRef] [PubMed]
  44. Arif, E.; Wagner, M.C.; Johnstone, D.B.; Wong, H.N.; George, B.; Pruthi, P.A.; Lazzara, M.J.; Nihalani, D. Motor protein Myo1c is a podocyte protein that facilitates the transport of slit diaphragm protein Neph1 to the podocyte membrane. Mol. Cell. Biol. 2011, 31, 2134–2150. [Google Scholar] [CrossRef] [Green Version]
  45. Krendel, M.; Kim, S.V.; Willinger, T.; Wang, T.; Kashgarian, M.; Flavell, R.A.; Mooseker, M.S. Disruption of myosin 1e promotes podocyte injury. J. Am. Soc. Nephrol. 2008, 20, 86–94. [Google Scholar] [CrossRef] [Green Version]
  46. Mele, C.; Iatropoulos, P.; Donadelli, R.; Calabria, A.; Maranta, R.; Cassis, P.; Buelli, S.; Tomasoni, S.; Piras, R.; Krendel, M.; et al. MYO1E Mutations and Childhood Familial Focal Segmental Glomerulosclerosis. N. Engl. J. Med. 2011, 365, 295–306. [Google Scholar] [CrossRef] [Green Version]
  47. Wagner, M.C.; Blazer-Yost, B.L.; Boyd-White, J.; Srirangam, A.; Pennington, J.; Bennett, S. Expression of the unconventional myosin Myo1c alters sodium transport in M1 collecting duct cells. Am. J. Physiol. Cell Physiol. 2005, 289, C120–C129. [Google Scholar] [CrossRef]
  48. Bi, J.; Chase, S.E.; Pellenz, C.D.; Kurihara, H.; Fanning, A.S.; Krendel, M. Myosin 1e is a component of the glomerular slit diaphragm complex that regulates actin reorganization during cell-cell contact formation in podocytes. Am. J. Physiol. Ren. Physiol. 2013, 305, F532–F544. [Google Scholar] [CrossRef] [Green Version]
  49. Batters, C.; Arthur, C.P.; Lin, A.; Porter, J.; A Geeves, M.; A Milligan, R.; E Molloy, J.; Coluccio, L.M. Myo1c is designed for the adaptation response in the inner ear. EMBO J. 2004, 23, 1433–1440. [Google Scholar] [CrossRef] [Green Version]
  50. Holt, J.R.; Gillespie, S.K.; Provance, D.; Shah, K.; Shokat, K.M.; Corey, D.P.; Mercer, J.; Gillespie, P.G. A chemical-genetic strategy implicates myosin-1c in adaptation by hair cells. Cell 2002, 108, 371–381. [Google Scholar] [CrossRef] [Green Version]
  51. Donaudy, F.; Ferrara, A.; Esposito, L.; Hertzano, R.; Ben-David, O.; Bell, R.E.; Melchionda, S.; Zelante, L.; Avraham, K.B.; Gasparini, P. Multiple mutations ofMYO1A, a cochlear-expressed gene, in sensorineural hearing loss. Am. J. Hum. Genet. 2003, 72, 1571–1577. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Chen, Y.-D.; Yan, B.; Chalovich, J.M.; Brenner, B. Theoretical kinetic studies of models for binding myosin subfragment-1 to regulated actin: Hill model versus Geeves model. Biophys. J. 2001, 80, 2338–2349. [Google Scholar] [CrossRef] [Green Version]
  53. Baek, J.-I.; Oh, S.-K.; Kim, D.-B.; Choi, S.-Y.; Kim, U.-K.; Lee, K.-Y.; Lee, S.-H. Targeted massive parallel sequencing: The effective detection of novel causative mutations associated with hearing loss in small families. Orphanet J. Rare Dis. 2012, 7, 60. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Inouye, M.; Ripatti, S.; Kettunen, J.; Lyytikäinen, L.-P.; Oksala, N.; Laurila, P.-P.; Kangas, A.J.; Soininen, P.; Savolainen, M.J.; Viikari, J.; et al. Novel loci for metabolic networks and multi-tissue expression studies reveal genes for atherosclerosis. PLoS Genet. 2012, 8, e1002907. [Google Scholar] [CrossRef]
  55. Tassopoulou-Fishell, M.; Deeley, K.; Harvey, E.M.; Sciote, J.; Vieira, A.R. Genetic variation in Myosin 1H contributes to mandibular prognathism. Am. J. Orthod. Dentofac. Orthop. 2012, 141, 51–59. [Google Scholar] [CrossRef] [Green Version]
  56. Toyoda, T.; An, D.; Witczak, C.A.; Koh, H.-J.; Hirshman, M.F.; Fujii, N.; Goodyear, L.J. Myo1c regulates glucose uptake in mouse skeletal muscle. J. Biol. Chem. 2011, 286, 4133–4140. [Google Scholar] [CrossRef] [Green Version]
  57. Sun, R.; Wang, Y.; Jin, M.; Chen, L.; Cao, Y.; Chen, F. Identification and functional studies of MYO1H for mandibular prognathism. J. Dent. Res. 2018, 97, 1501–1509. [Google Scholar] [CrossRef]
  58. Tyska, M.J.; Mackey, A.T.; Huang, J.-D.; Copeland, N.G.; Jenkins, N.A.; Mooseker, M.S. Myosin-1a is critical for normal brush border structure and composition. Mol. Biol. Cell 2005, 16, 2443–2457. [Google Scholar] [CrossRef] [Green Version]
  59. Arif, E.; Solanki, A.K.; Srivastava, P.; Rahman, B.; Tash, B.R.; Holzman, L.B.; Janech, M.G.; Martin, R.; Knölker, H.-J.; Fitzgibbon, W.R.; et al. The motor protein Myo1c regulates transforming growth factor-β–signaling and fibrosis in podocytes. Kidney Int. 2019, 96, 139–158. [Google Scholar] [CrossRef]
  60. Chase, S.E.; Encina, C.V.; Stolzenburg, L.R.; Tatum, A.H.; Holzman, L.B.; Krendel, M. Podocyte-specific knockout of myosin 1e disrupts glomerular filtration. Am. J. Physiol. Ren. Physiol. 2012, 303, F1099–F1106. [Google Scholar] [CrossRef] [Green Version]
  61. Kim, S.V.; Mehal, W.Z.; Dong, X.; Heinrich, V.; Pypaert, M.; Mellman, I.; Dembo, M.; Mooseker, M.S.; Wu, D.; Flavell, R.A. Modulation of cell adhesion and motility in the immune system by Myo1f. Science 2006, 314, 136–139. [Google Scholar] [CrossRef] [Green Version]
  62. Spielmann, M.; Hernandez-Miranda, L.R.; Ceccherini, I.; Weese-Mayer, D.E.; Kragesteen, B.K.; Harabula, I.; Krawitz, P.; Birchmeier, C.; Leonard, N.; Mundlos, S. Mutations in MYO1H cause a recessive form of central hypoventilation with autonomic dysfunction. J. Med. Genet. 2017, 54, 754–761. [Google Scholar] [CrossRef]
  63. Ruppert, C.; Kroschewski, R.; Bähler, M. Identification, characterization and cloning of myr 1, a mammalian myosin-I. J. Cell Biol. 1993, 120, 1393–1403. [Google Scholar] [CrossRef]
  64. Bähler, M.; Kroschewski, R.; E Stöffler, H.; Behrmann, T. Rat myr 4 defines a novel subclass of myosin I: Identification, distribution, localization, and mapping of calmodulin-binding sites with differential calcium sensitivity. J. Cell Biol. 1994, 126, 375–389. [Google Scholar] [CrossRef] [Green Version]
  65. Köhler, D.; Struchholz, S.; Bähler, M. The two IQ-motifs and Ca2+/calmodulin regulate the rat myosin 1d ATPase activity: Regulation of Myo1d ATPase activity. FEBS J. 2005, 272, 2189–2197. [Google Scholar] [CrossRef]
  66. Patino-Lopez, G.; Aravind, L.; Dong, X.; Kruhlak, M.J.; Ostap, E.M.; Shaw, S. Myosin 1G is an abundant class I Myosin in lymphocytes whose localization at the plasma membrane depends on its ancient divergent Pleckstrin Homology (PH) domain (Myo1PH). J. Biol. Chem. 2010, 285, 8675–8686. [Google Scholar] [CrossRef] [Green Version]
  67. Gupta, P.; Gauthier, N.C.; Cheng-Han, Y.; Zuanning, Y.; Pontes, B.; Ohmstede, M.; Martin, R.; Knölker, H.-J.; Döbereiner, H.-G.; Krendel, M.; et al. Myosin 1E localizes to actin polymerization sites in lamellipodia, affecting actin dynamics and adhesion formation. Biol. Open 2013, 2, 1288–1299. [Google Scholar] [CrossRef] [Green Version]
  68. Münnich, S.; Taft, M.H.; Manstein, D.J. Crystal structure of human myosin 1c—The motor in GLUT4 exocytosis: Implications for Ca2+ regulation and 14-3-3 binding. J. Mol. Biol. 2014, 426, 2070–2081. [Google Scholar] [CrossRef]
  69. Dart, A.E.; Tollis, S.; Bright, M.D.; Frankel, G.; Endres, R.G. The motor protein myosin 1G functions in FcγR-mediated phagocytosis. J. Cell Sci. 2012, 125, 6020–6029. [Google Scholar] [CrossRef] [Green Version]
  70. Swanson, J.; Johnson, M.; Beningo, K.; Post, P.; Mooseker, M.; Araki, N. A contractile activity that closes phagosomes in macrophages. J. Cell Sci. 1999, 112, 307–316. [Google Scholar] [CrossRef]
  71. Nambiar, R.; McConnell, R.E.; Tyska, M.J. Control of cell membrane tension by myosin-I. Proc. Natl. Acad. Sci. USA 2009, 106, 11972–11977. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  72. Gérard, A.; Patino-Lopez, G.; Beemiller, P.; Nambiar, R.; Ben-Aissa, K.; Liu, Y.; Totah, F.J.; Tyska, M.J.; Shaw, S.; Krummel, M.F. Detection of rare antigen-presenting cells through T cell-intrinsic meandering motility, mediated by Myo1g. Cell 2014, 158, 492–505. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  73. López-Ortega, O.; Ovalle-García, E.; Ortega-Blake, I.; Antillón, A.; Chávez-Munguía, B.; Patiño-López, G.; Fragoso-Soriano, R.; Santos-Argumedo, L. Myo1g is an active player in maintaining cell stiffness in B-lymphocytes: Myo1g mediates cell stiffness in B-lymphocytes. Cytoskeleton 2016, 73, 258–268. [Google Scholar] [CrossRef] [PubMed]
  74. Diz-Munoz, A.; Krieg, M.; Bergert, M.; Ibarlucea-Benitez, I.; Muller, D.J.; Paluch, E.; Heisenberg, C.-P. Control of directed cell migration in vivo by membrane-to-cortex attachment. PLoS Biol. 2010, 8, e1000544. [Google Scholar] [CrossRef]
  75. Cordonnier, M.-N.; Dauzonne, D.; Louvard, D.; Coudrier, E. Actin filaments and myosin I alpha cooperate with microtubules for the movement of lysosomes. Mol. Biol. Cell 2001, 12, 4013–4029. [Google Scholar] [CrossRef]
  76. Raposo, G.; Cordonnier, M.-N.; Tenza, D.; Menichi, B.; Dürrbach, A.; Louvard, D.; Coudrier, E. Association of myosin I alpha with endosomes and lysosomes in mammalian cells. Mol. Biol. Cell 1999, 10, 1477–1494. [Google Scholar] [CrossRef] [Green Version]
  77. Salas-Cortes, L.; Ye, F.; Tenza, D.; Wilhelm, C.; Theos, A.; Louvard, D.; Raposo, G.; Coudrier, E. Myosin Ib modulates the morphology and the protein transport within multi-vesicular sorting endosomes. J. Cell Sci. 2005, 118, 4823–4832. [Google Scholar] [CrossRef] [Green Version]
  78. McIntosh, B.; Pyrpassopoulos, S.; Holzbaur, E.L.; Ostap, E.M. Opposing kinesin and myosin-I motors drive membrane deformation and tubulation along engineered cytoskeletal networks. Curr. Biol. 2018, 28, 236–248.e5. [Google Scholar] [CrossRef]
  79. Chugh, P.; Paluch, E.K. The actin cortex at a glance. J. Cell Sci. 2018, 131, jcs186254. [Google Scholar] [CrossRef] [Green Version]
  80. Wang, F.-S.; Liu, C.-W.; Diefenbach, T.J.; Jay, D.G. Modeling the role of myosin 1c in neuronal growth cone turning. Biophys. J. 2003, 85, 3319–3328. [Google Scholar] [CrossRef] [Green Version]
  81. Maravillas-Montero, J.L.; Gillespie, P.G.; Patiño-López, G.; Shaw, S.; Santos-Argumedo, L. Myosin 1c participates in B cell cytoskeleton rearrangements, is recruited to the immunologic synapse, and contributes to antigen presentation. J. Immunol. 2011, 187, 3053–3063. [Google Scholar] [CrossRef] [Green Version]
  82. Schauer, K.; Duong, T.; Bleakley, K.; Bardin, S.; Bornens, M.; Goud, B. Probabilistic density maps to study global endomembrane organization. Nat. Methods 2010, 7, 560–566. [Google Scholar] [CrossRef]
  83. Grossier, J.-P.; Xouri, G.; Goud, B.; Schauer, K. Cell adhesion defines the topology of endocytosis and signaling. EMBO J. 2014, 33, 35–45. [Google Scholar] [CrossRef]
  84. McIntosh, B.B.; Holzbaur, E.L.; Ostap, E.M. Control of the initiation and termination of kinesin-1-driven transport by myosin-Ic and nonmuscle tropomyosin. Curr. Biol. 2015, 25, 523–529. [Google Scholar] [CrossRef] [Green Version]
  85. Tang, N.; Ostap, E. Motor domain-dependent localization of myo1b (myr-1). Curr. Biol. 2001, 11, 1131–1135. [Google Scholar] [CrossRef] [Green Version]
  86. Collins, K.; Sellers, J.R.; Matsudaira, P. Calmodulin dissociation regulates brush border myosin I (110-kD-calmodulin) mechanochemical activity in vitro. J. Cell Biol. 1990, 110, 1137–1147. [Google Scholar] [CrossRef] [Green Version]
  87. Kee, A.J.; Yang, L.; Lucas, C.A.; Greenberg, M.J.; Martel, N.; Leong, G.M.; Hughes, W.E.; Cooney, G.J.; James, D.E.; Ostap, E.M.; et al. An actin filament population defined by the tropomyosin Tpm3.1 regulates glucose uptake. Traffic 2015, 16, 691–711. [Google Scholar] [CrossRef]
  88. Joensuu, M.; Belevich, I.; Rämö, O.; Nevzorov, I.; Vihinen, H.; Puhka, M.; Witkos, T.M.; Lowe, M.; Vartiainen, M.K.; Jokitalo, E. ER sheet persistence is coupled to myosin 1c–regulated dynamic actin filament arrays. Mol. Biol. Cell 2014, 25, 1111–1126. [Google Scholar] [CrossRef]
  89. Soldati, T. Unconventional myosins, actin dynamics and endocytosis: A ménage à trois?: Myosins, actin dynamics and endocytosis. Traffic 2003, 4, 358–366. [Google Scholar] [CrossRef] [Green Version]
  90. Jung, G.; Remmert, K.; Wu, X.; Volosky, J.M.; Hammer, J.A. The dictyostelium carmil protein links capping protein and the Arp2/3 complex to type I myosins through their Sh3 domains. J. Cell Biol. 2001, 153, 1479–1498. [Google Scholar] [CrossRef]
  91. Geli, M.I.; Lombardi, R.; Schmelzl, B.; Riezman, H. An intact SH3 domain is required for myosin I-induced actin polymerization. EMBO J. 2000, 19, 4281–4291. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  92. Manenschijn, H.E.; Picco, A.; Mund, M.; Rivier-Cordey, A.-S.; Ries, J.; Kaksonen, M. Type-I myosins promote actin polymerization to drive membrane bending in endocytosis. eLife 2019, 8, e44215. [Google Scholar] [CrossRef] [PubMed]
  93. Wollenberg, R.D.; Taft, M.H.; Giese, S.; Thiel, C.; Balázs, Z.; Giese, H.; Manstein, D.J.; Sondergaard, T.E. Phenamacril is a reversible and noncompetitive inhibitor of Fusarium class I myosin. J. Biol. Chem. 2019, 294, 1328–1337. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Biology 11 00989 g001 550
Figure 1. Characteristic protein domain organization of class 1 myosins modified from [1].
Figure 1. Characteristic protein domain organization of class 1 myosins modified from [1].
Biology 11 00989 g001
Biology 11 00989 g002 550
Figure 2. The actin–myosin interface. (A) The Myo1b motor domain bound to F-actin (with only 3 actin subunits). (B) Actin (left) and myosin (right) surfaces (within a 5 Å distance of each other) are colored according to the surface electrostatic potential distribution (red −5; blue 5 KbT/ec). (C) Residues making inter-protein contacts (within 4 Å distance) are shown as balls. Right, the myosin actin-binding structural elements are shown in different colors. Left, actin residues are colored depending on the myosin structural elements that contact them. This figure was provided by Olena Pylypenko, UMR144/Institut Curie. The figure was made based on an experimental cryo-EM structure of Myo1B (PDB ID 6C1H) from (Mentes et al. [12]).
Figure 2. The actin–myosin interface. (A) The Myo1b motor domain bound to F-actin (with only 3 actin subunits). (B) Actin (left) and myosin (right) surfaces (within a 5 Å distance of each other) are colored according to the surface electrostatic potential distribution (red −5; blue 5 KbT/ec). (C) Residues making inter-protein contacts (within 4 Å distance) are shown as balls. Right, the myosin actin-binding structural elements are shown in different colors. Left, actin residues are colored depending on the myosin structural elements that contact them. This figure was provided by Olena Pylypenko, UMR144/Institut Curie. The figure was made based on an experimental cryo-EM structure of Myo1B (PDB ID 6C1H) from (Mentes et al. [12]).
Biology 11 00989 g002
Table
Table 1. Localizations and functions of myosin 1 paralogs.
Table 1. Localizations and functions of myosin 1 paralogs.
Myosin NameLocalizationsFunctionsReferences
Myo1AIntestineLinker between actin bundles and the microvillus membrane in miceBenesh, A.E. [16]
Myo1BLung, liver, heart, and brainInteracts with EPHB2 and controls cell repulsion and morphology (Hek293T or HCT116 cells)Prospéri, M.-T. [17]
Prospéri, M.-T. [18]
Regulates the formation of filopodia in growth cones in neuronsIuliano, O. [19]
Promotes the formation of tubules at the Trans-Golgi Network (HeLa cells)Almeida, C.G. [20]
Facilitates tube extraction (in vitro, rat Myo1B)Yamada, A. [21]
Acts as an actin depolymerase (in vitro, rat Myo1B)Pernier, J. [22]
Affects branched F-actin (in vitro, rat Myo1B)Almeida, C.G. [20]
Pernier, J. [23]
Myo1CUbiquitously expressedMechanical transduction in the ear (mouse Myo1c)Lin, T. [24]
Regulation of cellular membrane tension (Dictyostelium)Dai, J. [25]
Cholesterol transport (HeLa cells)Brandstaetter, H. [26]
Tethering of vesicles (mouse Myo1c, hTERT-RPE1 cells)Boguslavsky, S. [27]
Capmany, A. [28]
Autophagosome-lysosome fusion (HeLa cells)Brandstaetter, H. [29]
Chirality establishment in DrosophilaLebreton, G. [30]
Pyrpassopoulos, S. [31]
Docking of GLUT4-containing vesicles to the plasma membrane in muscle and adipocytesBoguslavsky, S. [27]
Bose, A. [32]
Bose, A. [33]
Yip, M.F. [34]
Chen, X.-W. [35]
Huang, S. [36]
Controls exocytosis in secretory cellsTiwari, A. [37]
Kittelberger, N. [38]
Chromatin modifications to gene transcription and cell cycle progression in nucleus (HeLa cells)Sarshad, A. [39]
Myo1DWidely expressed, high expression in brainInfluences the establishment of rotational planar cell polarity in epithelial cells of the tracheaHegan, P.S. [40]
Myo1EHematopoietic cellsInvolved in clathrin-mediated endocytosisLechler, T. [41]
Cheng, J. [42]
Myo1FHematopoietic cellsRegulates adhesionKim, S.V. [15]
Myo1GHematopoietic cellsInvolved in phagocytosis and exocytosis processesMaravillas-Montero, J.L. [43]
Table
Table 2. Diseases associated with myosin 1 paralog mutations.
Table 2. Diseases associated with myosin 1 paralog mutations.
Myosin NameAmino Acid MutationEffect and Associated DiseaseReference
Myo1AInsertion between 349 and 350DeafnessDonaudy, F. [51]
V306MDeafness
E385DAffect ATPase activity Deafness
G662EDeafness
G647DDeafness
S797FDeafness
S910PDeafness
Myo1C690STOPNo recruitment of Neph1, glomerular diseaseArif, E. [44]
Y61GIncreased sensitivity to inhibition, hair cells defectHolt, J.R. [50]
R156WDecreased myosin duty ratio and force sensitivity, hearing lossLin, T. [24]
K111A (in Mouse)Glucose uptake defectsToyoda, T. [56]
Myo1EA159PAbnormal localization and function, glomerulosclerosisMele, C. [46]
Y695STOPLoss of calmodulin binding at the tail domain of Myo1E, glomerulosclerosis
A159PNo efficient assembly of actin cables along cell-cell junctions, glomerular diseaseBi, J. [48]
Myo1FI502VDestabilized actin binding site and ATP binding site, hearing lossBaek, J.-I. [53]
Myo1HP1001LMandibular prognathismSun, R. [57]
Table
Table 3. Genetic studies and experiments using murine models of myosin-I.
Table 3. Genetic studies and experiments using murine models of myosin-I.
Myosin NameGenetic ModificationPhenotypesReferences
Myo1AComplete knockoutNo overt phenotypes at the whole animal, defects in microvillar membrane morphology and in brush-border organizationTyska, M.J. [58]
Myo1B--
Myo1CComplete knockoutRetinal phenotypes onlyArif, E. [59]
Myo1CPodocytes-specific knockoutDownregulation of canonical and non-canonical TGF-β pathwaysArif, E. [59]
Myo1DComplete knockoutPerturbed planar cell polarity of epithelial cells of the trachea, change of velocity and linearity of cilia-driven movement, loss of asymmetric clustering of cilia of ependymal cells and left-right positioning of the clusters, no obvious motor defects of rats, no obvious differences in kidney and liver morphologyHegan, P.S. [40]
Myo1EComplete knockoutNephrotic syndrome and focal segmental glomerulosclerosisKrendel, M. [45]
Myo1EPodocytes-specific knockoutProteinuria, podocyte foot process effacement, glomerular basement membrane disorganization, anormal glomerular filtrationChase, S.E. [60]
Myo1FComplete knockoutIncreased susceptibility to infection by Listeria monocytogenes and an impaired neutrophil responseKim, S.V. [61]
Myo1GComplete knockoutAbnormalities in the adhesion ability and chemokine-induced directed migration in B lymphocytesMaravillas-Montero, J.L. [43]
Myo1HComplete knockoutSevere cyanosis and death within the first four postnatal hoursSpielmann, M. [62]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Pernier, J.; Schauer, K. Does the Actin Network Architecture Leverage Myosin-I Functions? Biology 2022, 11, 989. https://doi.org/10.3390/biology11070989

AMA Style

Pernier J, Schauer K. Does the Actin Network Architecture Leverage Myosin-I Functions? Biology. 2022; 11(7):989. https://doi.org/10.3390/biology11070989

Chicago/Turabian Style

Pernier, Julien, and Kristine Schauer. 2022. "Does the Actin Network Architecture Leverage Myosin-I Functions?" Biology 11, no. 7: 989. https://doi.org/10.3390/biology11070989

APA Style

Pernier, J., & Schauer, K. (2022). Does the Actin Network Architecture Leverage Myosin-I Functions? Biology, 11(7), 989. https://doi.org/10.3390/biology11070989

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop